NCT06043401View on ClinicalTrials.gov

Tracking Brain Biomarkers and Renormalization Associated With Antidepressant Transcranial Magnetic Stimulation Therapy

Active, not recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Major Depressive Disorder
Interventions
OTHER

Neuroimaging with Magnetic Resonance Imaging (MRI)

MRI will be used to observe brain states over time.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER